Article: PP4.4 A retrospective study of 109 patients with essential thrombocythemia with a focus on the delay in the diagnosis

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma